Patent application number | Description | Published |
20090180280 | MULTI-ACTION, BATTERY-POWERED, TRIGGER-ACTIVATED LIGHTING SYSTEM - A multi-action, battery-powered, trigger-activated lighting system automatically provides soft light upon human motion during the night, even in the event of a power outage, and can additionally be deployed quickly for use as an intense flashlight. Furthermore, it can provide low-battery indication to prompt the user to install fresh batteries whenever necessary, before a critical need arises. | 07-16-2009 |
20120171923 | Method for an Oscillating Moving Display - An efficient battery powered oscillating mobile comprises of a mobile, elastic cord, free standing module assembly, plurality of keeper fasteners, and external rigid anchor point. The mobile comprises of an outer shell, which comprises of a printed circuit board assembly, hole, tab, and cord. The printed circuit board assembly comprises of a printed circuit board, motor, motor shaft, metal arm, and cross beam. Each keeper fastener comprises of keeper fingers, blade screwdriver slot, keeper head, and keeper shaft. The free standing module comprises of a power source assembly, housing mechanism, motor assembly, catch, catch slot, plurality of slots, sliding guide, printed circuit board assembly, electrical contact pin, plurality of retainer holes, snap locks, switch spring system, cord adaptor, coin cells, and keeper spring. | 07-05-2012 |
20130133218 | HAIR DRYER - A hair dryer including a main body having a handle and a housing. The hair dryer includes a first module and a second module, both selectably coupleable and thereby functionally coupleable to the main body. The first module and the second module each include a hair dryer component selected from the group of hair dryer components consisting of a heater module and a blower module. The first module is a blower module including a motor. The second module is a heater module including a heating element. The first module includes an identification device configured to identify a characteristic of the first module and wherein the housing includes a communication module configured to read an identification device and communicate a read characteristic to a control module. The hair dryer includes a plurality of interchangeable first modules that include varying operational characteristics. | 05-30-2013 |
20130160316 | HAIR DRYING DEVICE - A hair drying device including a tube with selectably adjustable apertures. There is a remote and portable blower, wherein the hand piece does not include any logical control circuits. There is a sleeve slidably coupled to a tube wherein apertures of the sleeve and tube align to provide a plurality of aperture configurations when the sleeve is rotated relative to the tube. | 06-27-2013 |
20140144037 | HAIR DRYING DEVICE - A hair dryer including a blower and a dryer head having a narrow elongated nozzle shaped to generate airflow in the form of a thin blade of air. The hair dryer includes an airflow evening structure functionally coupled to the nozzle that more evenly distribute airflow of the thin blade of air. The airflow evening structure is a sleeve rotatably coupled about the nozzle and includes a plurality of diversely shaped nozzle masks disposed about the sleeve, each shaped to restrict airflow through the nozzle in varying modes. | 05-29-2014 |
20140216493 | HAIR STRAIGHTENING IRON - A hair straightening iron including and an air heating device in air flow with the blower. The hair straightening iron includes a hose functionally coupled to the blower. The hair straightening iron includes an iron in airflow communication with the air heating device. The iron includes a body consisting essentially of a material having a thermal conductivity of greater than about 0.1 kW/(m*K). The iron includes an interior channel within the body having an effective ratio of channel area to cross-sectional flow area greater than about 90. The interior channel includes a plurality of heat transfer vanes. The iron includes a straight edge extending along a length of the body and including an elongated nozzle extending along a majority of the length of the straight edge through which heated air exits the iron. The nozzle includes an array of holes. | 08-07-2014 |
Patent application number | Description | Published |
20090326688 | Systems and Methods for Fitting Golfers with Golf Clubs - Golf club fitting systems and methods include: (a) receiving input data indicating a golfer's driver loft angle and shaft flexibility characteristic; (b) determining initial candidate fairway wood clubs based on this data; and (c) identifying the initial candidate fairway wood clubs. Such systems and methods further may include: (d) receiving launch monitor data generated when the golfer hits balls using the initial candidate fairway wood clubs; (e) determining and identifying additional candidate fairway wood clubs for testing; (f) receiving launch monitor data generated when the golfer hits balls using the additional candidate fairway wood clubs; and (g) determining and identifying a recommendation for a final first fairway wood club based on the data. Other clubs in the fitted set also may be determined by these fitting systems and methods. | 12-31-2009 |
20100216563 | SYSTEM FOR DETERMINING PERFORMANCE CHARACTERISTICS OF A GOLF SWING - An instrumented golf club system and methods are disclosed. A variety of golf swing parameters are measured by the instrumented golf club and wirelessly transmitted to a portable computer device. The portable computer device generates a user interface that displays the golf swing parameters against preferred golf swing parameters. The instrumented golf club system allows a golfer to receive feedback in real time while playing golf. | 08-26-2010 |
20100216564 | SYSTEM FOR DETERMINING PERFORMANCE CHARACTERISTICS OF A GOLF SWING - An instrumented golf club system and methods are disclosed. A variety of golf swing parameters are measured by the instrumented golf club and wirelessly transmitted to a portable computer device. The portable computer device generates a user interface that displays the golf swing parameters against preferred golf swing parameters. The instrumented golf club system allows a golfer to receive feedback in real time while playing golf. | 08-26-2010 |
20100216565 | SYSTEM FOR DETERMINING PERFORMANCE CHARACTERISTICS OF A GOLF SWING - An instrumented golf club system and methods are disclosed. A variety of golf swing parameters are measured by the instrumented golf club and wirelessly transmitted to a portable computer device. The portable computer device generates a user interface that displays the golf swing parameters against preferred golf swing parameters. The instrumented golf club system allows a golfer to receive feedback in real time while playing golf | 08-26-2010 |
20130203518 | GOLF CLUBS AND GOLF CLUB HEADS - Golf clubs according to at least some example aspects of this disclosure may include a golf club head and a shaft configured to engage with the golf club head which includes a grip engaged with the shaft. Further, the golf club may include a monitoring device, which includes a sensor and a transmitter. Additionally, the monitoring device may be configured to determine data related to the characteristics of a golf swing. Further, the monitoring device may be configured to transmit the data related to the characteristics of a golf swing to a remote computer. | 08-08-2013 |
20130303295 | GOLF CLUBS AND GOLF CLUB HEADS HAVING DIGITAL LIE AND/OR OTHER ANGLE MEASURING EQUIPMENT - Golf club heads having sensors configured to measure one or more swing parameters are provided. The golf club head may include several gyroscopes and accelerometers. In one embodiment, the club head contains three gyroscopes that measure angular rate data along different orthogonal axes. At least one gyroscope may an analog gyroscope. Accelerometers may provide data regarding the three orthogonal axes associated with the gyroscopes. The club head may further include software and/or hardware that perform computer-executed methods for determining one or more swing parameters. Exemplary club heads may include a display device for displaying an output of the swing parameter(s). Further aspects of the invention relate to novel methods and algorithms for calculating measurements relating to the swing parameters. | 11-14-2013 |
20140274437 | Vibration Modes Of Faces For Golf Club Heads Or Other Ball Striking Devices - A ball striking device, such as a golf club head, includes a face having a ball striking surface configured for striking a ball and a body connected to the face and extending rearward from the face. The head further has an indicator associated therewith, the indicator identifying a golf ball based on a vibration mode of the golf ball, such that the club head is configured to be used to strike the golf ball on the ball striking surface. In one embodiment, the face and the identified golf ball(s) may have the same or substantially the same vibration mode at one or more different swing speeds. The indicator may be positioned on the body or elsewhere on the club head, or may be alternately be positioned on a shaft connected to the head or separately from the ball striking device, such as in a written manual associated with the head. | 09-18-2014 |
20140323235 | GOLF CLUBS AND GOLF CLUB HEADS HAVING DIGITAL LIE AND/OR OTHER ANGLE MEASURING EQUIPMENT - Golf club heads having sensors configured to measure one or more swing parameters are provided. The golf club head may include several gyroscopes and accelerometers. In one embodiment, the club head contains three gyroscopes that measure angular rate data along different orthogonal axes. At least one gyroscope may an analog gyroscope. Accelerometers may provide data regarding the three orthogonal axes associated with the gyroscopes. The club head may further include software and/or hardware that perform computer-executed methods for determining one or more swing parameters. Exemplary club heads may include a display device for displaying an output of the swing parameter(s). Further aspects of the invention relate to novel methods and algorithms for calculating measurements relating to the swing parameters. | 10-30-2014 |
Patent application number | Description | Published |
20090155291 | METHOD OF INCREASING IMMUNOLOGICAL EFFECT - A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape. | 06-18-2009 |
20100047182 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and predicting a treatment outcome. Methods of detecting defects in monocyte or T lymphocyte function, including the steps of administering an effective amount of an NCM or T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and detecting at least one defect in monocyte or T lymphocyte function. A mechanism for indicating a functioning efferent or afferent limb of an immune system, including a diagnostic skin test including an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. | 02-25-2010 |
20100047205 | VACCINE IMMUNOTHERAPY - The present invention provides compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions. According to one embodiment of the invention, a composition is provided for eliciting an immune response to at (east one antigen in a patient having an antigen-producing disease or lesion, the composition comprising an effective amount of a cytokine mixture, preferably comprising IL-1, IL-2, IL-6, IL-8, IFN-γ (gamma) and TNF-α (alpha). The cytokine mixture acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the immune response of the patient to the antigen. Methods are therefore also provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion utilizing the cytokine mixture of the invention. The compositions and methods are useful in the treatment of antigen-producing diseases such as cancer, infectious diseases or persistent lesions. | 02-25-2010 |
20110044941 | IMMUNOTHERAPY FOR REVERSING IMMUNE SUPPRESSION - A method for overcoming immune suppression includes the steps of inducing production of naïve T cells and restoring T cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naïve T cells and exposing the naïve T cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions; preferably the natural cytokine mixture is administered in combination with thymosin α | 02-24-2011 |
20110076249 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - The present invention provides compositions of a natural cytokine mixture (NCM) for treating a cellular immunodeficiency characterized by T lymphocytopenia, one or more dendritic cell functional defects such as those associated with lymph node sinus histiocytosis, and/or one or more monocyte functional defects such as those associated with a negative skin test to NCM. The invention includes methods of treating these cellular immunodeficiencies using the NCM of the invention. The compositions and methods are useful in the treatment of diseases associated with cellular immunodeficiencies such as cancer. Also provided are compositions and methods for reversing tumor-induced immune suppression comprising a chemical inhibitor and a non-steroidal anti-inflammatory drug (NSAID). The invention also provides a diagnostic skin test comprising NCM for predicting treatment outcome in cancer patients. | 03-31-2011 |
20110081313 | MECHANISM OF ACTION OF PRIMARY CELL DERIVED BIOLOGIC - A method of treating an immune target that is suppressing the immune system and restoring the immune system, including the steps of administering an effective amount of a primary cell derived biologic, modifying populations of B and T cells in blood, activating regional lymph nodes, infiltrating an area adjacent to an immune target with T helper and B cells, infiltrating the immune target with T killer cells and macrophages, and treating the immune target and restoring the immune system. A method of inducing immunization in a patient. A method of destroying a tumor. A method of predicting a favorable treatment outcome to cancer treatment. A method of immune prophylaxis. A method of immune restoration. A method of treating a tumor. A method of preventing tumor escape. | 04-07-2011 |
20110110884 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - The present invention provides compositions of a natural cytokine mixture (NCM) for treating a cellular immunodeficiency characterized by T lymphocytopenia, one or more dendritic cell functional defects such as those associated with lymph node sinus histiocytosis, and/or one or more monocyte functional defects such as those associated with a negative skin test to NCM. The invention includes methods of treating these cellular immunodeficiencies using the NCM of the invention. The compositions and methods are useful in the treatment of diseases associated with cellular immunodeficiencies such as cancer. Also provided are compositions and methods for reversing tumor-induced immune suppression comprising a chemical inhibitor and a non-steroidal anti-inflammatory drug (NSAID). The invention also provides a diagnostic skin test comprising NCM for predicting treatment outcome in cancer patients. | 05-12-2011 |
20120064035 | VACCINE IMMUNOTHERAPY - A composition for treating cancer, including synergistic amounts of a primary cell-derived biologic having the cytokines IL-1, IL-2, IL-6, IL-8, TNF-α, and IFN-γ, and a cancer vaccine having at least one antigen. A composition comprising synergistic amounts of the primary cell-derived biologic in combination with at least one adjuvant. A method of treating cancer by administering the composition. A method of reversing immune suppression and gaining immunity to cancer. A method of producing an immune response to an exogenous antigen. A method of enhancing an immune response in a patient by administering the primary cell-derived biologic in combination with at least one adjuvant, and enhancing the immune response of the patient by a synergistic interaction of the primary cell-derived biologic and the adjuvant. A method of increasing function of an immune system. | 03-15-2012 |
20130164255 | IMMUNOTHERAPY FOR REVERSING IMMUNE SUPPRESSION - A method for overcoming immune suppression includes the steps of inducing production of naive T cells and restoring T cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naive T cells and exposing the naive T cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions; preferably the natural cytokine mixture is administered in combination with thymosin α | 06-27-2013 |
20130171192 | ADJUVANT FORMULATIONS FOR BACTERIAL AND VIRUS VACCINES AND METHOD OF MAKING SAME - A pharmaceutical composition including an adjuvant effective amount of a protected inosine monophosphate (IMP) compound. The pharmaceutical composition includes the protected IMP compound alone, or in combination with vaccine agents with or without additional adjuvants. The pharmaceutical composition can be utilized as a vaccine composition or can be included with existing vaccine compositions in order to increase a specific T lymphocyte mediated immune response thereto. Various methods relating to the pharmaceutical composition and the vaccine are described herein. The vaccines can be employed to prevent or treat infections. Additionally, the pharmaceutical compositions not only increase T-cell responses, but also confer, by pretreatment, non-specific protection against a variety of pathogens. This combination of actions is appropriate for enhancing defense against bioterrorism with organisms like smallpox and anthrax. | 07-04-2013 |
20130243723 | VACCINE IMMUNOTHERAPY - A composition for treating cancer, including synergistic amounts of a primary cell-derived biologic having the cytokines IL-1, IL-2, IL-6, IL-8, TNF-α, and IFN-γ, and a cancer vaccine having at least one antigen. A composition comprising synergistic amounts of the primary cell-derived biologic in combination with at least one adjuvant. A method of treating cancer by administering the composition. A method of reversing immune suppression and gaining immunity to cancer. A method of producing an immune response to an exogenous antigen. A method of enhancing an immune response in a patient by administering the primary cell-derived biologic in combination with at least one adjuvant, and enhancing the immune response of the patient by a synergistic interaction of the primary cell-derived biologic and the adjuvant. A method of increasing function of an immune system. | 09-19-2013 |
20140010780 | VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A method for overcoming mild to moderate immune suppression includes the steps of inducing production of naive T-cells and restoring T-cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naive T-cells and exposing the naive T-cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T-cells to gain immunization of the T-cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions. | 01-09-2014 |
20140023593 | IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A diagnostic skin test for predicting treatment outcome, consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A kit for performing a skin test consisting essentially of an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. A method of performing a skin test on a patient, consisting essentially of the steps of administering an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and predicting a treatment outcome. Methods of detecting defects in monocyte or T lymphocyte function, including the steps of administering an effective amount of an NCM or T lymphocyte mitogen of muromonab-CD3 to skin, analyzing results of the skin test, and detecting at least one defect in monocyte or T lymphocyte function. A mechanism for indicating a functioning efferent or afferent limb of an immune system, including a diagnostic skin test including an effective amount of an NCM or a T lymphocyte mitogen of muromonab-CD3. | 01-23-2014 |
20140030217 | VACCINE IMMUNOTHERAPY - The present invention provides compositions and methods of immunotherapy to treat cancer or other antigen-producing diseases or lesions. According to one embodiment of the invention, a composition is provided for eliciting an immune response to at (east one antigen in a patient having an antigen-producing disease or lesion, the composition comprising an effective amount of a cytokine mixture, preferably comprising IL-1, IL-2, IL-6, IL-8, IFN γ (gamma) and TNF-α (alpha). The cytokine mixture acts as an adjuvant with the antigen associated with the antigen-producing disease or lesion to enhance the immune response of the patient to the antigen. Methods are therefore also provided for eliciting an immune response to at least one antigen in a patient having an antigen-producing disease or lesion utilizing the cytokine mixture of the invention. The compositions and methods are useful in the treatment of antigen-producing diseases such as cancer, infectious diseases or persistent lesions. | 01-30-2014 |
20140348782 | VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A method for overcoming mild to moderate immune suppression includes the steps of inducing production of naive T-cells and restoring T-cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naive T-cells and exposing the naive T-cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T-cells to gain immunization of the T-cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions. | 11-27-2014 |
20140348783 | VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS - A method for overcoming mild to moderate immune suppression includes the steps of inducing production of naive T-cells and restoring T-cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naive T-cells and exposing the naive T-cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T-cells to gain immunization of the T-cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions. | 11-27-2014 |
Patent application number | Description | Published |
20090243169 | SYSTEMS FOR DAMPING VIBRATIONS FROM A PAYLOAD - Systems are provided for damping vibrations from a payload. In an embodiment, and by way of example only, the system includes an isolation strut and a gas line. The isolation strut includes a bellows and a piston. The bellows has a first end and a second end, the first end being enclosed, and the second end attached to the piston to define a chamber. The piston includes a damping annulus therethrough having a gas inlet and a gas outlet. The gas inlet provides flow communication to the chamber of the bellows. The gas line is coupled to the isolation strut and is in fluid communication with the gas outlet thereof. The system is hermetically sealed to contain a gas therein. | 10-01-2009 |
20120267506 | THREE PARAMETER, MULTI-AXIS ISOLATORS, ISOLATION SYSTEMS EMPLOYING THE SAME, AND METHODS FOR PRODUCING THE SAME - Embodiments of a three parameter, multi-axis isolator configured to limit the transmission of vibrations between a mass and a base are provided. In one embodiment, the three parameter, multi-axis isolator includes an isolator housing configured to be mounted to the base, opposing bellows sealingly mounted within the isolator housing, and a damper piston movably suspended within the isolator housing between the opposing bellows. The damper piston is configured to be coupled to the mass. The opposing bellows deflect with movement of the damper piston along multiple axes to limit the transmission of vibrations between the mass and the base. | 10-25-2012 |
20120292476 | THERMALLY-CONDUCTIVE VIBRATION ISOLATORS AND SPACECRAFT ISOLATION SYSTEMS EMPLOYING THE SAME - Embodiments of a thermally-conductive vibration isolator are provided, as are embodiments of a spacecraft isolation employing a plurality of thermally-conductive vibration isolators. In one embodiment, the thermally-conductive vibration isolator includes a first end portion, a second end portion substantially opposite the first end portion, and first and second load transfer paths from the first end portion to the second end portion. The first and second load transfer paths comprise a main spring and a damper in parallel with the main spring, respectively. An elongated thermal conduit, which has a thermal conductivity exceeding that of first load transfer path and the second load transfer path, extends from the first end portion to the second end portion. | 11-22-2012 |
20130051981 | GAS TURBINE ENGINES INCLUDING BROADBAND DAMPING SYSTEMS AND METHODS FOR PRODUCING THE SAME - Gas turbine engine, broadband damping systems, and methods for producing broadband-damped gas turbine engine are provided. In one embodiment, the gas turbine engine includes an engine case, a rotor assembly mounted within the engine case for rotation about a rotational axis, and a broadband damping system disposed between the rotor assembly and the engine case. The broadband damping system includes a first set of three parameter axial dampers angularly spaced around the rotational axis, and a second set of three parameter axial dampers angularly spaced around the rotational axis and coupled in parallel with the first set of three parameter axial dampers. The first and second sets of three parameter axial dampers are tuned to provide peak damping at different rotational frequencies to increase the damping bandwidth of the broadband damping system during operation of the gas turbine engine. | 02-28-2013 |
20130134257 | RESILIENT AIRCRAFT ENGINE MOUNTS AND AIRCRAFT ENGINE MOUNTING SYSTEMS INCLUDING THE SAME - Resilient aircraft engine mounts and mounting systems including the same are provided. A resilient aircraft engine mount comprises a base and a pair of opposed spiral springs in parallel forming a clevis with the base. A first spiral spring of the pair of opposed spiral springs has a first center opening extending therethrough. A second spiral spring of the pair of opposed spiral springs has a second center opening extending therethrough that is concentric with the first center opening for accepting a clevis pin. First and second spiral springs are each comprised of a rectangular cross section beam. The resilient aircraft engine mount is tunable in three translational axes to support three degrees of freedom vibration isolation. Two or more resilient aircraft engine mounts provide six degrees of freedom vibration isolation. Resilient aircraft engine mounts attach the aircraft engine to a pylon structure and help isolate vibratory forces. | 05-30-2013 |
20130154170 | PASSIVE ISOLATION DEVICES PROVIDING LOW FREQUENCY DAMPING OF LOW MASS PAYLOADS AND SPACECRAFT ISOLATION SYSTEMS EMPLOYING THE SAME - Embodiments of a low frequency isolation device are provided, as are embodiments of a spacecraft isolation system including a plurality of low frequency isolation devices. In one embodiment, the low frequency isolation device includes a three parameter isolator and a break frequency-reducing series spring mechanically coupled in series with the three parameter isolator and having a predetermined axial stiffness (K | 06-20-2013 |